Navigation Links
Prime Therapeutics Receives VIPPS Accreditation
Date:5/21/2008

ST. PAUL, Minn., May 21 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that it has received accreditation from the National Association of Boards of Pharmacy(R) (NABP(R)) through its Verified Internet Pharmacy Practice Sites(TM) (VIPPS(R)) Program.

Prime has met the VIPPS standards established by NABP in response to consumers' concerns regarding the safety of pharmacy practices on the Internet. VIPPS accreditation further authenticates Prime's Web-based pharmacy services as a reputable, accredited source of prescription drugs. PrimeMail(R), Prime's mail-service pharmacy, uses the Internet as a safe and convenient way for members to place orders and provides access to a number of useful pharmacy tools.

"Prime's top priority is ensuring that clients and members are continually receiving the highest quality care and service," said Keith McFalls, Vice President of PrimeMail. "VIPPS accreditation further demonstrates Prime's commitment to providing unmatched member safety and satisfaction while empowering clients with tools and information to aid in making more informed health care management decisions."

To become VIPPS accredited, a pharmacy must comply with the licensing and inspection requirements in each state they dispense pharmaceuticals. In addition, pharmacies that are VIPPS accredited have demonstrated to NABP compliance with VIPPS criteria, including: patient rights to privacy, authentication and security of prescription orders, adherence to a recognized quality assurance policy, and provision of meaningful consultation between patients and pharmacists.

Prime began the VIPPS accreditation process in April 2007 and received official accreditation confirmation on March 5, 2008. Prime's Web services provide a wide range of pharmacy benefit information and protects member confidentiality with password protections, encryption, firewalls and secure links. Member Web sites also include useful tools such as drug research options that allow members to review specific drug information, a complete prescription history list and a cost calculator that offers side by side cost comparisons of brand-name and generic drugs at both PrimeMail and retail pharmacies.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 (legal) million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by ten Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

NABP is the independent, international, and impartial Association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Primera Biosystems Raises $21 Million in Series B Private Round
2. Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
3. ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results
4. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Nile Therapeutics Reports 2008 First Quarter Financial Results
6. Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
7. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
8. Amicus Therapeutics Announces First Quarter 2008 Financial Results
9. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
11. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... ... mass flow controllers based on capillary thermal mass flow technology provide exponentially more ... control applications. Over 80% of all industrial processes—such as those involving chemical ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... joined other scientists, researchers, engineers, and industry professionals in visiting U.S. Congressional offices ... to compete in the world photonics industry. , This year, National Photonics ...
(Date:4/27/2017)... April 27, 2017  Pendant Biosciences, Inc. (formerly Nanoferix, ... modification and drug delivery technologies, today announced that it ... @ Toronto . ... Pendant Biosciences, noted, "We are excited to become part ... community, and are honored to be the first ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... Lajollacooks4u, San Diego’s premiere team-building and cooking events company, offers one-of-a-kind gifts, ranging ... , Menus specialize in California cuisine, and guests leave inspired with new cooking ...
Breaking Biology Technology:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):